(Q36528736)

English

Clinical efficacy of plasmapheresis in patients with neuromyelitis optica spectrum disorder and effects on circulating anti-aquaporin-4 antibody levels

scientific article published on 3 January 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 August 2017

Clinical efficacy of plasmapheresis in patients with neuromyelitis optica spectrum disorder and effects on circulating anti-aquaporin-4 antibody levels (English)

1 reference

Europe PubMed Central

14 August 2017

neuromyelitis optica

1 reference

based on heuristic

inferred from title

author name string

Su-Hyun Kim

1

1 reference

Europe PubMed Central

14 August 2017

Woojun Kim

2

1 reference

Europe PubMed Central

14 August 2017

So-Young Huh

3

1 reference

Europe PubMed Central

14 August 2017

Kyue Yim Lee

4

1 reference

Europe PubMed Central

14 August 2017

In Ja Jung

5

1 reference

Europe PubMed Central

14 August 2017

Ho Jin Kim

6

1 reference

Europe PubMed Central

14 August 2017

publication date

3 January 2013

1 reference

Europe PubMed Central

14 August 2017

Journal of clinical neurology

1 reference

Europe PubMed Central

14 August 2017

9

1 reference

Europe PubMed Central

14 August 2017

1

1 reference

Europe PubMed Central

14 August 2017

36-42

1 reference

Europe PubMed Central

14 August 2017

copyright license

Creative Commons Attribution-NonCommercial 3.0 Unported

1 January 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Plasma exchange in severe attacks of neuromyelitis optica

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543908

30 September 2017

New insights into neuromyelitis optica

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543908

30 September 2017

Current and future treatment approaches for neuromyelitis optica

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543908

30 September 2017

Beneficial plasma exchange response in central nervous system inflammatory demyelination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543908

30 September 2017

Efficacy of plasmapheresis for the treatment of severe toxic epidermal necrolysis: Is cytokine expression analysis useful in predicting its therapeutic efficacy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543908

30 September 2017

The rescue effect of plasma exchange for neuromyelitis optica

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543908

30 September 2017

Introduction and overview of therapeutic apheresis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543908

30 September 2017

Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543908

30 September 2017

EFNS guidelines on diagnosis and management of neuromyelitis optica

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543908

30 September 2017

Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543908

30 September 2017

Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543908

30 September 2017

Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543908

30 September 2017

The spectrum of neuromyelitis optica

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543908

30 September 2017

Plasma exchange in neuroimmunological disorders: Part 1: Rationale and treatment of inflammatory central nervous system disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543908

30 September 2017

Revised diagnostic criteria for neuromyelitis optica

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543908

30 September 2017

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543908

30 September 2017

Plasma exchange: why we do what we do.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543908

30 September 2017

The clinical course of neuromyelitis optica (Devic's syndrome).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543908

30 September 2017

Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543908

28 June 2018

Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543908

21 September 2018

NMO-IgG predicts the outcome of recurrent optic neuritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543908

21 September 2018

Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543908

21 September 2018

Quantitative measurement of anti-aquaporin-4 antibodies by enzyme-linked immunosorbent assay using purified recombinant human aquaporin-4

1 reference

https://pubmed.ncbi.nlm.nih.gov/23346159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma exchange for severe attacks of CNS demyelination: predictors of response

1 reference

https://pubmed.ncbi.nlm.nih.gov/23346159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23346159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3988/JCN.2013.9.1.36

1 reference

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36528736&oldid=1865818338"